| 1 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D00729 
                
                    D00729
                
             | 
                
                    Loperamide
                
             | 2件:  13 13, 97 | 
| 2 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D00843 
                
                    D00843
                
             | 
                
                    Nalbuphine
                
             | 1件:  85 85 | 
| 3 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D01340 
                
                    D01340
                
             | 
                
                    Naloxone
                
             | 2件:  6 6, 226 | 
| 4 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D02095 
                
                    D02095
                
             | 
                
                    Naltrexone
                
             | 13件:  6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 | 
| 5 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D03783 
                
                    D03783
                
             | 
                
                    Oxycodone
                
             | 7件:  6 6, 13, 46, 70, 226, 231, 298 | 
| 6 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D05111 
                
                    D05111
                
             | 
                
                    Nalmefene
                
             | 1件:  6 6 | 
| 7 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D05113 
                
                    D05113
                
             | 
                
                    Naltrexone
                
             | 13件:  6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 | 
| 8 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D05312 
                
                    D05312
                
             | 
                
                    Oxycodone
                
             | 7件:  6 6, 13, 46, 70, 226, 231, 298 | 
| 9 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D05462 
                
                    D05462
                
             | 
                
                    Oxycodone
                
             | 7件:  6 6, 13, 46, 70, 226, 231, 298 | 
| 10 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D07113 
                
                    D07113
                
             | 
                
                    Loperamide
                
             | 2件:  13 13, 97 | 
| 11 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D08144 
                
                    D08144
                
             | 
                
                    Loperamide
                
             | 2件:  13 13, 97 | 
| 12 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D08246 
                
                    D08246
                
             | 
                
                    Nalbuphine
                
             | 1件:  85 85 | 
| 13 | 
                
                    OPRD1
                
             | 3件:  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | D08249 
                
                    D08249
                
             | 
                
                    Naloxone
                
             | 2件:  6 6, 226 |